Chunkang Chang

Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders

Chunkang Chang, Barry E. Storer, Bart L. Scott et al. · Blood · 2007 · 154 citations · Full text

Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway

Qingqing Zheng, Youshan Zhao, Juan Guo et al. · Cell Death and Disease · 2018 · 110 citations · Full text

Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring

Feng Xu, Xiao Li, Lingyun Wu et al. · Annals of Hematology · 2010 · 99 citations

Hematological Malignancy, Chromatin, Medicine +12

<i>TP53</i> mutations predict decitabine‐induced complete responses in patients with myelodysplastic syndromes

Chunkang Chang, Youshan Zhao, Feng Xu et al. · British Journal of Haematology · 2016 · 76 citations · Full text

Mixed-phenotype Acute Leukemia, Genetics, Genetic Epidemiology +21

Chidamide, a novel histone deacetylase inhibitor, inhibits the viability of MDS and AML cells by suppressing JAK2/STAT3 signaling.

Sida Zhao, Juan Guo, Youshan Zhao et al. · PubMed · 2016 · 70 citations · Full text

Chemoprevention Strategy, Immunology, Cell Death +17